Association of Interleukin-6 and C-Reactive Protein With Subclinical Carotid Atherosclerosis (the Rancho Bernardo Study)

American Journal of Cardiology

Volumn 99, Issue 1, 2007, Pages 99-102

  Lee, Won Young ^a,b   Allison, Matthew A ^a   Kim, Dong Jun ^a,c   Song, Chan Hee ^a,d   Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERIES; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 33845717106     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.07.070     Document Type: Article

References (17)

1. Criqui M.H., Barrett-Connor E., and Austin M. Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol 108 (1978) 367-372
2. O'Leary D.H., Polak J.F., Kronmal R.A., Kittner S.J., Bond M.G., Wolfson Jr. S.K., Bommer W., Price T.R., Gardin J.M., and Savage P.J. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study: the CHS Collaborative Research Group. Stroke 23 (1992) 1752-1760
3. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., and Wolfson Jr. S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340 (1999) 14-22
4. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 337 (1997) 973-979
5. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
6. Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A., Hutchinson W.L., and Pepys M.B. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
7. Wilson P.W., Nam B.H., Pencina M., D'Agostino Sr. R.B., Benjamin E.J., and O'Donnell C.J. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med 165 (2005) 2473-2478
8. Folsom A.R., Pankow J.S., Tracy R.P., Arnett D.K., Peacock J.M., Hong Y., Djousse L., and Eckfeldt J.H. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 88 (2001) 112-117
9. Tracy R.P., Psaty B.M., Macy E., Bovill E.G., Cushman M., Cornell E.S., and Kuller L.H. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 17 (1997) 2167-2176
10. Sitzer M., Markus H.S., Mendall M.A., Liehr R., Knorr U., and Steinmetz H. C-reactive protein and carotid intimal medial thickness in a community population. J Cardiovasc Risk 9 (2002) 97-103
11. Chapman C.M., Beilby J.P., McQuillan B.M., Thompson P.L., and Hung J. Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke 35 (2004) 1619-1624
12. Redberg R.F., Rifai N., Gee L., and Ridker P.M. Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. J Am Coll Cardiol 36 (2000) 39-43
13. Hunt M.E., O'Malley P.G., Vernalis M.N., Feuerstein I.M., and Taylor A.J. C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J 141 (2001) 206-210
14. van der Meer I.M., de Maat M.P., Bots M.L., Breteler M.M., Meijer J., Kiliaan A.J., Hofman A., and Witteman J.C. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study. Arterioscler Thromb Vasc Biol 22 (2002) 838-842
15. Wang T.J., Nam B.H., Wilson P.W., Wolf P.A., Levy D., Polak J.F., D'Agostino R.B., and O'Donnell C.J. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 22 (2002) 1662-1667
16. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., Lowe G.D., Pepys M.B., and Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
17. Kenis G., Teunissen C., De Jongh R., Bosmans E., Steinbusch H., and Maes M. Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine 19 (2002) 228-235